BSE: 532803 | NSE: POCHIRAJU | Floriculture | Small Cap
Data is not available for this company.
The key valuation ratios of Pochiraju Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 14.3% | 13.2% | 8.9% | 11.2% | 3.4% | -30.9% | -29.6% | -4.8% | -4.6% | -5.1% | - |
| Value Creation Index ⓘ | 0.0 | -0.1 | -0.4 | -0.2 | -0.8 | -3.2 | -3.1 | -1.3 | -1.3 | -1.4 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 55.4 | 72.4 | 109 | 120 | 139 | 9.7 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | 30.7% | 50.3% | 10% | 16.2% | -93.1% | -100% | NA | NA | NA | - |
| Adj EPS ⓘ | 6.2 | 7.9 | 2.8 | 5.5 | 0.6 | -27.4 | -20.2 | -5.8 | -2 | -2.1 | -2.1 |
| YoY Gr. | - | 26.8% | -65% | 99.3% | -88.9% | -4588.5% | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 43.8 | 52.1 | 53.7 | 63.3 | 63.9 | 36.5 | 23.5 | 17.7 | 15.7 | 13.6 | 15.2 |
| Adj Net Profit ⓘ | 11.7 | 14.9 | 5.2 | 10.4 | 1.2 | -51.8 | -38.1 | -11.1 | -3.8 | -4 | -4 |
| Cash Flow from Ops. ⓘ | 11.7 | 13.3 | 7.5 | 2.6 | 45.9 | -0.1 | 0 | 0 | 0 | 0 | - |
| Debt/CF from Ops. ⓘ | 1.1 | 2.2 | 4.1 | 15.4 | 1.1 | -540.4 | -10176.3 | -77111.2 | -97079.5 | -2332241.6 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | -100% | NA | NA | ||||
| Adj EPS ⓘ | -188.8% | -228.4% | NA | NA | ||||
| BVPSⓘ | -12.2% | -26.6% | -16.8% | -13.6% | ||||
| Share Price | - | - | - | - | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 12.3 | 13.4 | 4.3 | 8 | 0.9 | -47.2 | -58.9 | -27.6 | -11.5 | -14 | -14.7 |
| Op. Profit Mgn % ⓘ | 25.3 | 23 | 15.7 | 18.6 | 6.9 | -412.8 | 0 | 0 | 0 | 0 | NAN |
| Net Profit Mgn % ⓘ | 21.1 | 20.5 | 4.8 | 8.7 | 0.8 | -535.3 | 0 | 0 | 0 | 0 | -INF |
| Debt to Equity ⓘ | 0.2 | 0.3 | 0.3 | 0.3 | 0.4 | 0.7 | 1.1 | 1.5 | 1.6 | 1.9 | - |
| Working Cap Days ⓘ | 180 | 148 | 122 | 171 | 149 | 890 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 144 | 118 | 100 | 132 | 100 | 525 | 0 | 0 | 0 | 0 | 0 |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -2.1 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 15.2 | - |
| Reserves (₹ Cr.) ⓘ | 10 | - |
| P/BV ⓘ | 0.13 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 3.10 / 3.43 |
| All Time Low / High (₹) | 2.65 / 88.10 |
| Market Cap (₹ Cr.) | 3.7 |
| Equity (₹ Cr.) | 18.9 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 189.1 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55.44 | 72.43 | 108.86 | 119.74 | 139.12 | 9.67 | 0 | 0 | 0 | 0 |
| Operating Expenses ⓘ | 41.40 | 55.75 | 91.82 | 97.50 | 129.59 | 49.60 | 16.93 | 0.64 | 0.16 | 0.34 |
| Manufacturing Costs | 3.21 | 6.47 | 15.41 | 6.84 | 19.78 | 3.16 | 0.01 | 0.07 | 0 | 0 |
| Material Costs | 34.36 | 43.74 | 65.07 | 81.31 | 93.01 | 12.57 | 0 | 0 | 0 | 0 |
| Employee Cost | 2.07 | 2.88 | 4.10 | 3.78 | 3.93 | 0.96 | 0.04 | 0.09 | 0.01 | 0 |
| Other Costs ⓘ | 1.76 | 2.65 | 7.23 | 5.56 | 12.86 | 32.91 | 16.88 | 0.48 | 0.15 | 0.34 |
| Operating Profit ⓘ | 14.04 | 16.69 | 17.04 | 22.24 | 9.54 | -39.93 | -16.93 | -0.64 | -0.16 | -0.34 |
| Operating Profit Margin (%) | 25.3% | 23.0% | 15.7% | 18.6% | 6.9% | -412.0% | - | - | - | - |
| Other Income ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest ⓘ | 0.24 | 0.10 | 4.84 | 5.42 | 6.67 | 6.80 | 6.80 | 6.80 | 0 | 0.07 |
| Depreciation ⓘ | 1.73 | 1.73 | 5.32 | 5.71 | 3.96 | 4.69 | 14.59 | 3.60 | 3.60 | 3.60 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 12.07 | 14.86 | 6.88 | 11.11 | -1.10 | -51.42 | -38.32 | -11.05 | -3.76 | -4.02 |
| Tax ⓘ | 0.35 | 0 | 1.67 | 0.74 | -2.24 | 0.35 | -0.22 | 0 | 0 | 0 |
| Profit After Tax | 11.72 | 14.86 | 5.21 | 10.37 | 1.15 | -51.77 | -38.11 | -11.05 | -3.76 | -4.02 |
| PAT Margin (%) | 21.1% | 20.5% | 4.8% | 8.7% | 0.8% | -535.0% | - | - | - | - |
| Adjusted EPS (₹) | 6.2 | 7.9 | 2.8 | 5.5 | 0.6 | -27.4 | -20.2 | -5.8 | -2.0 | -2.1 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 101.31 | 117.68 | 122.89 | 133.26 | 134.38 | 82.61 | 44.50 | 33.46 | 29.69 | 25.67 |
| Share Capital ⓘ | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 | 18.91 |
| Reserves ⓘ | 82.41 | 98.78 | 103.98 | 114.35 | 115.48 | 63.70 | 25.60 | 14.55 | 10.79 | 6.77 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 13.26 | 28.78 | 23.24 | 31.19 | 29.55 | 29.55 | 29.55 | 29.55 | 48.51 | 48.51 |
| Long Term Debt | 13.26 | 28.78 | 23.24 | 15.48 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 | 7.47 |
| Short Term Debt | 0 | 0 | 0 | 15.71 | 22.08 | 22.08 | 22.08 | 22.08 | 41.04 | 41.04 |
| Trade Payables | 0.49 | 0.23 | 0.27 | 0.25 | 0.55 | 0.51 | 0.86 | 1.50 | 0.47 | 0.47 |
| Others Liabilities ⓘ | 1.88 | 1.81 | 10.30 | 13.87 | 21.38 | 28.54 | 35.12 | 41.93 | 24.15 | 24.56 |
| Total Liabilities ⓘ | 116.95 | 148.51 | 156.69 | 178.57 | 185.86 | 141.20 | 110.03 | 106.43 | 102.82 | 99.22 |
Fixed Assets | ||||||||||
| Gross Block | 19.04 | 87.52 | 87.52 | 87.52 | 98.64 | 98.64 | 94.41 | 94.41 | 94.41 | 94.41 |
| Accumulated Depreciation | 9.64 | 11.37 | 16.69 | 22.40 | 26.27 | 30.95 | 45.54 | 49.14 | 52.75 | 56.35 |
| Net Fixed Assetsⓘ | 9.40 | 76.15 | 70.83 | 65.12 | 72.37 | 67.68 | 48.87 | 45.27 | 41.66 | 38.06 |
| CWIP ⓘ | 58.15 | 21.19 | 21.75 | 29.54 | 56.34 | 56.34 | 60.56 | 60.56 | 60.56 | 60.56 |
| Investmentsⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 7.46 | 6.95 | 10.59 | 21.74 | 10.39 | 0 | 0 | 0 | 0 | 0 |
| Trade Receivables | 15.40 | 18.03 | 24.75 | 30.15 | 14.88 | 3.04 | 0 | 0 | 0 | 0 |
| Cash Equivalents | 2.64 | 1.39 | 0.75 | 0.23 | 0.10 | 0.01 | 0 | 0 | 0 | 0 |
| Others Assetsⓘ | 23.90 | 24.80 | 28.02 | 31.79 | 31.79 | 14.13 | 0.59 | 0.59 | 0.59 | 0.59 |
| Total Assets ⓘ | 116.95 | 148.51 | 156.69 | 178.57 | 185.86 | 141.20 | 110.03 | 106.43 | 102.82 | 99.22 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 11.69 | 13.34 | 7.53 | 2.63 | 45.91 | -0.09 | 0 | 0 | 0 | 0 |
| PBT ⓘ | 12.07 | 14.86 | 6.88 | 11.11 | -1.10 | -51.42 | -38.32 | -11.05 | -3.76 | -4.02 |
| Adjustment ⓘ | 1.92 | 1.79 | 10.12 | 11.09 | 10.59 | 11.49 | 28.13 | 3.60 | 3.60 | 3.60 |
| Changes in Working Capital ⓘ | -1.76 | -3.25 | -4.68 | -13.88 | 43.04 | 39.84 | 10.19 | 7.44 | 0.16 | 0.41 |
| Tax Paid ⓘ | -0.35 | 0 | 0 | -0.31 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Investing Activity ⓘ | -24.67 | -31.20 | -2.61 | -11.11 | -38.04 | 0 | 0 | 0 | 0 | 0 |
| Capex | -7.99 | -31.52 | -0.56 | -11.11 | -23.61 | 0 | 0 | 0 | 0 | 0 |
| Net Investments | -2.36 | 0 | -2.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | -14.32 | 0.32 | 0 | 0 | -14.42 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activityⓘ | 14.91 | 16.61 | -5.55 | 7.95 | -8.01 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Shares ⓘ | 3.55 | 1.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 11.36 | 15.53 | -5.55 | 7.95 | -8.01 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow ⓘ | 1.94 | -1.25 | -0.63 | -0.52 | -0.13 | -0.09 | 0 | 0 | 0 | 0 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 15.09 | 16.39 | 5.21 | 9.37 | 0.95 | -54.52 | -67.1 | -28.34 | -11.92 | -14.52 |
| ROCE (%) | 14.31 | 13.21 | 8.94 | 11.23 | 3.36 | -30.86 | -29.62 | -4.79 | -4.63 | -5.11 |
| Asset Turnover Ratio | 0.54 | 0.55 | 0.71 | 0.71 | 0.76 | 0.06 | 0 | 0 | 0 | 0 |
| PAT to CFO Conversion(x) | 1 | 0.9 | 1.45 | 0.25 | 39.92 | N/A | N/A | N/A | N/A | N/A | Working Capital Days |
| Receivable Days | 98 | 84 | 72 | 84 | 59 | 338 | 0 | 0 | 0 | 0 |
| Inventory Days | 49 | 36 | 29 | 49 | 42 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 4 | 3 | 1 | 1 | 2 | 15 | 0 | 0 | 0 | 0 |
The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh certificate of incorporation was obtained on September 10, 2003 from Registrar of Companies, Coimbatore
The company is currently focusing on three business segments – Agri Business, Pharmaceuticals and Bio-Technology & Life Sciences. The organizational structure of the company is designed for effective management of multiple business, while retaining focus on each one of them.
Pharmapil is the Pharma Division of PIL, operating its range of pharmaceutical formulations on a national level through aggressive, dynamic and committed field force of over 250 medical representatives. Pharmapil will have two divisions, the General and the Specialty divisions and market products in tablet, capsule, liquid, injectable, powder and ointment dosage forms.
Biopil is the Biotechnology Division of PIL. A state of art plant is under construction spread over 3.86 acres of land in the S. P. Biotechnology Park situated at Turkapally, Shamirpet, Hyderabad. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering and structure based molecular design which are part of modern Biotechnology. The product range shall include biosimilar products, such as Erythropoietin, G-CSF, Interferon Alpha, Interferon Beta, Human Growth Hormone and Recombinant Human Insulin. Biopil will have its own in house Research and Development Laboratory attached to a Common Quality Control, Documentation and Quality Assurance Laboratory.
Agropil is the Agricultural Division of PIL. From a modest start of 3 hectare of green house, it has gradually expanded its floriculture business to 6 hectare of green house and has established its presence in domestic as well as overseas markets. It will be engaged in developing hybrid varieties and genetically modified seeds, bio-fertilizers, bio-pesticides and plant growth stimulants in agriculture
Prouct range of the company include:
Pharma Division
Biotechnology Division
Agricultural Division
Recently the company grown the different varieties of roses consisting different colours such as red, yellow, pink, white, peach etc. The companys flowers and varieties are known for their quality, stem length, bud size with good foliage, free from any pest and disease.
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Claim your FREE 15-day access to the most practical investing handbook.
Hurry, limited to the first 10 users today!
Become a savvy and confident
stock investor.
Don't miss out! First 10 users today get it FREE
Download APP
